Target intelligence / Profile preview

Nicotinic acetylcholine receptor subunit monepantel-1 (MPTL-1)

Target
MPTL-1
Molecular classification
Ligand-gated ion channel, Ion channel, Receptor
01

Overview

Nicotinic acetylcholine receptor subunit monepantel‑1 (MPTL‑1), also known as ACR‑23 in Caenorhabditis elegans, is a member of the DEG‑3 subfamily of nicotinic acetylcholine receptors. These are ligand-gated ion channels found specifically in nematodes and are not present in mammals. The primary biological function is mediating signal transduction via nonselective monovalent cation conductance upon activation by agonists such as betaine or synthetic anthelmintics like monepantel. Activation leads to depolarization and subsequent paralysis of the parasite. This target is central to the mechanism of action for amino-acetonitrile derivative (AAD) class anthelmintics, with monepantel acting as a super agonist at this site[2][3]. Mutations or mis-splicing events affecting this gene confer resistance to these drugs among parasitic nematodes such as Haemonchus contortus[3]. No cross-resistance has been observed between AADs targeting this receptor and other classes like imidazothiazoles[1].

Other names
ACR-23MPTL-1Acetylcholine receptor monepantel-1
02

Mechanism of action

Agonist activation of the nicotinic acetylcholine receptor subunit, leading to nematode paralysis and death[2][3].

03

Biological functions

Signal transduction
04

Disease associations

Infection (specifically, nematode parasitic infections)
05

Safety considerations

Potential for resistance development in target nematodes due to mutations in the acr‑23/mptl‑1 gene[3].
06

Interacting drugs

Monepantel

Beyond the preview

Go deeper on Nicotinic acetylcholine receptor subunit monepantel-1 (MPTL-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicotinic acetylcholine receptor subunit monepantel-1 (MPTL-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call